Phospholipid derivatized with PEG bifunctional linker and liposo

Details Phospholipid derivatized with PEG bifunctional linker and liposo Phospholipid derivatized with PEG bifunctional linker and liposo

1994-01-19

1996-09-17

Kim, Kay K. A.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

5303911, 424450, 4241781, 548119, C07K 1702, C07K 1600, C07F 910, A61K 9127

Patent

active

055569480

ABSTRACT:
A phospholipid derivative of the following formula (I): ##STR1## wherein A is a residue of a phospholipid having a phosphatidylethanolamine moiety, and B is a linking group having a polyalkylene glycol moiety.

REFERENCES:
patent: 4429008 (1984-01-01), Martin et al.
patent: 5045451 (1991-09-01), Lihr et al.
patent: 5059421 (1991-10-01), Loughrey et al.
patent: 5264221 (1993-11-01), Tagawa et al.
Borrebaeck, Journal of Immunological Methods, vol. 123, pp. 157-165 (1989).
Waldmann, Science, vol. 252, pp. 1657-1662 (1991).
Hermentin et al., Behring Inst. Mitt., No. 82, pp. 197-215 (1988).
Canevari et al., Ann Oncol., vol. 5/8, pp. 698-701 (1994).
Antisense Research and Development, vol. 2, No. 3, pp. 187-197, 1992, S. M. Sullivan, et al., "Inhibition of Human Immunodeficiency Virus-1 Proliferation by Liposome-Encapsulated Sense DNA to the 5' TAT Splice Acceptor Site".
Biochimica et Biophysica Acta, vol. 1061, pp. 56-64, 1991, T. M. Allen, et al., "Uptake of Liposomes by Cultured Mouse Bone Marrow Macrophages: Influence of Liposome Composition and Size".
Proc. Natl. Acad. Sci. USA, vol. 87, pp. 5744-5748, Aug. 1990, K. Maruyama, et al., "Lipid Composition is Important for Highly Efficient Target Binding and Retention of Immunoliposomes".
Nature, vol. 288, pp. 602-604, Dec. 1980, L. D. Leserman, et al., "Targeting to Cells of Fluorescent Liposomes Covalently Coupled with Monoclonal Antibody of Protein A".
The Journal of Biological Chemistry, vol. 255, No. 17, pp. 8015-8018, Sep. 10, 1980, A. Huang, et al., "Monoclonal Antibody Covalently Coupled with Fatty Acid".
The Journal of Biological Chemistry, vol. 257, No. 1, pp. 286-288, Jan. 10, 1982, F. J. Martin, et al., "Irreversible Coupling of Immunoglobulin Fragments to Preformed Vesicles".
Federation of European Biochemical Societies, vol. 284, No. 2, pp. 263-266, Jun. 1991, A. Mori, et al., "Influence of the Steric Barrier Activity of Amphipathic Poly(Ethyleneglycol) and Ganglioside GM1 on the Circulation Time of Liposomes and on the Target Binding of Immunoliposomes In Vivo".
Cancer Research, vol. 47, pp. 4471-4477, Aug. 15, 1987, H. Konno, et al., "Antitumor Effect of Adriamycin Entrapped in Liposomes Conjugated with Anti-Human .alpha.-Fetoprotein Monoclonal Antibody".
Cancer Research, vol. 43, pp. 5328-5334, Nov. 1983, Y. Hashimoto, et al., "Antitumor Effect of Actinomycin D Entrapped in Liposomes Bearing Subunits of Tumor-Specific Monoclonal Immunoglobulin M Antibody".
Biochimica et Biophysica Acta, vol. 1066, pp. 29-36, 1991, T. M. Allen, et al., "Liposomes Containing Synthetic Lipid Derivatives of Poly(Ethylene Gylcol) Show Prolonged Circulation Half-Lives In Vivo".
Journal of Liposome Research, vol.2, No.3, pp. 321-334, 1992, A. L. Klibanov, et al., "Long-Circulating Liposomes: Development and Perspectives".
Advanced Drug Delivery Reviews, vol.3, pp. 343-389, 1989, S. Wright, et al., "Antibody-Directed Liposomes as Drug-Delivery Vehicles".
Cancer Research, vol.52, pp. 4817-4820, Sep. 1, 1992, I. Ahmad, et al., "Antibody-Mediated Specific Binding and Cytotoxicity of Liposome-Entrapped Doxorubin to Lung Cancer Cells In Vitro".
Biochimica et Biophysica Acta, vol. 1062, pp. 142-148, 1991, A. L. Klibanov, et al., "Activity of Amphipathic Poly(Ethylene Glycol) 5000 to Prolong the Circulation Time of Liposomes Depends on the Liposome Size and is Unfavorable for Immunoliposome Binding to Target".
Federation of European Biochemical Societies Letters, vol.268, No. 1, pp. 235-237, Jul. 1990, A. L. Klibanov, et al. "Amphipathic Polyethyleneglycols Effectively Prolong the Circulation Time Liposomes".

Affiliated with

Also associated with

Rating

Phospholipid derivatized with PEG bifunctional linker and liposo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phospholipid derivatized with PEG bifunctional linker and liposo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipid derivatized with PEG bifunctional linker and liposo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-413999